Bank of New York Mellon Corp Grows Stock Holdings in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Bank of New York Mellon Corp boosted its holdings in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 9.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 390,788 shares of the company’s stock after buying an additional 34,455 shares during the quarter. Bank […]
Bank of New York Mellon Corp boosted its holdings in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 9.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 390,788 shares of the company’s stock after buying an additional 34,455 shares during the quarter. Bank […]
